ATE170522T1 - Aminoalkylcarbamatester von eserolin verwendbar als inhibitoren von cholinesteraseaktivität und verfahren zu deren herstellung - Google Patents

Aminoalkylcarbamatester von eserolin verwendbar als inhibitoren von cholinesteraseaktivität und verfahren zu deren herstellung

Info

Publication number
ATE170522T1
ATE170522T1 AT93109932T AT93109932T ATE170522T1 AT E170522 T1 ATE170522 T1 AT E170522T1 AT 93109932 T AT93109932 T AT 93109932T AT 93109932 T AT93109932 T AT 93109932T AT E170522 T1 ATE170522 T1 AT E170522T1
Authority
AT
Austria
Prior art keywords
eseroline
esters
inhibitors
aminoalkylcarbamate
usable
Prior art date
Application number
AT93109932T
Other languages
English (en)
Inventor
Maria Alessandra Alisi
Mario E Brufani
Maria Candida Cesta
Luigi Filocamo
Gianluca Gostoli
Sperandina Lappa
Pier Giuseppe Pagella
Enrico Ferrari
Stefano Maiorana
Donata Marchesini
Original Assignee
Mediolanum Farmaceutici Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mediolanum Farmaceutici Srl filed Critical Mediolanum Farmaceutici Srl
Application granted granted Critical
Publication of ATE170522T1 publication Critical patent/ATE170522T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
AT93109932T 1992-06-25 1993-06-22 Aminoalkylcarbamatester von eserolin verwendbar als inhibitoren von cholinesteraseaktivität und verfahren zu deren herstellung ATE170522T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921559A IT1254996B (it) 1992-06-25 1992-06-25 Esteri amminoalchilcarbammici dell'eserolina atti all'impiego come anticolinesterasici e relativo procedimento di preparazione

Publications (1)

Publication Number Publication Date
ATE170522T1 true ATE170522T1 (de) 1998-09-15

Family

ID=11363576

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93109932T ATE170522T1 (de) 1992-06-25 1993-06-22 Aminoalkylcarbamatester von eserolin verwendbar als inhibitoren von cholinesteraseaktivität und verfahren zu deren herstellung

Country Status (8)

Country Link
US (2) US5302593A (de)
EP (1) EP0575954B1 (de)
JP (1) JPH06206882A (de)
KR (1) KR940005627A (de)
AT (1) ATE170522T1 (de)
CA (1) CA2099648A1 (de)
DE (1) DE69320705D1 (de)
IT (1) IT1254996B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6133444A (en) * 1993-12-22 2000-10-17 Perseptive Biosystems, Inc. Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
IT1271679B (it) * 1994-07-18 1997-06-04 Mediolanum Farmaceutici Srl Derivati del fenilcarbammato atti all'impiego come anticolinesterasici
DE69632324T2 (de) * 1995-06-07 2005-06-16 PerSeptive Biosystems, Inc., Framingham Pna-dna-chimäre und pna-synthone zu deren herstellung
US5952506A (en) * 1997-04-24 1999-09-14 American Home Products Corporation Process for the synthesis of 4- 6- (hexylcarbamoyloxy) hexylcarbamoyloxy!-piperidine-1-carboxylic acid 4-phenoxyphenyl ester
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
AU2011215870B2 (en) * 2010-02-09 2016-01-28 The Johns Hopkins University Methods and compositions for improving cognitive function
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
JP6433482B2 (ja) 2013-03-15 2018-12-05 エージンバイオ， インコーポレイテッド 認知機能を改善するための方法および組成物
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
WO2016191288A1 (en) 2015-05-22 2016-12-01 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
EP0513703A3 (en) * 1991-05-13 1993-01-13 Magis Farmaceutici S.P.A. Carbamate esters of eseroline having anticholinesterase activity, a process for their preparation and relative pharmaceutical compositions containing them as the active principle

Also Published As

Publication number Publication date
ITMI921559A0 (it) 1992-06-25
EP0575954A1 (de) 1993-12-29
IT1254996B (it) 1995-10-11
DE69320705D1 (de) 1998-10-08
ITMI921559A1 (it) 1993-12-25
KR940005627A (ko) 1994-03-22
US5424451A (en) 1995-06-13
US5302593A (en) 1994-04-12
CA2099648A1 (en) 1993-12-26
EP0575954B1 (de) 1998-09-02
JPH06206882A (ja) 1994-07-26

Similar Documents

Publication Publication Date Title
ATE233730T1 (de) Acylsulfamoylbenzoesäureamide, diese enthaltende nutzpflanzenschützende mittel und verfahren zu ihrer herstellung
TW237455B (de)
ATE149999T1 (de) Monofluorierte derivate von n-propargyl-1- aminoindan und deren verwendung als monoamino- oxidaseinhibitoren
DE3868308D1 (de) Heterozyklische derivate, verfahren zu deren herstellung und diese enthaltende radiosensibilisierende agenzien und antivirale agenzien.
ATE236119T1 (de) Phenylessigsäurederivate, verfahren und zwischenprodukte zu ihrer herstellung und sie enthaltende mittel
DE68907057D1 (de) Naehrstoffzusammensetzung und verfahren zu deren herstellung.
DE3763421D1 (de) Polybuten- und polyisobutenamine, verfahren zu deren herstellung und diese enthaltende kraft- und schmierstoffzusammensetzungen.
ATE205837T1 (de) Chinoxaline, verfahren zu ihrer herstellung und ihre verwendung
DE69430116D1 (de) Optisches Halbleitermodul und Verfahren zu seiner Herstellung
DE3783503D1 (de) Pyridylacrylsaeureester-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
ATE165601T1 (de) Benzopyran-verbindungen, verfahren zu ihrer herstellung und ihre verwendung als zellenschutzmittel
ATE317912T1 (de) Verfahren zur herstellung von beta-lactamen
ATE170522T1 (de) Aminoalkylcarbamatester von eserolin verwendbar als inhibitoren von cholinesteraseaktivität und verfahren zu deren herstellung
DE69415159D1 (de) Succinamid-derivate, verfahren zu ihrer herstellung und ihre verwendung als gelatinase- und collagenase- inhibitoren
ATE77817T1 (de) 3-cyan-pyridine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
PT1086096E (pt) Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4
DE69116783D1 (de) Laserdiodenmodul und Verfahren zu seiner Herstellung
DE69427440D1 (de) Härtbare, einen anaerob inaktiven Hydrosilylierungskatalysator enthaltende Zusammensetzungen und Verfahren zu deren Herstellung
DE69619259D1 (de) Amidin- und isothioharnstoffderivate als inhibitoren der stickstoffoxid-synthase
ATE24316T1 (de) 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln.
DK0532530T3 (da) Derivater af 6-amino-octahydroindolizintriol
DE3673468D1 (de) N-alkyl-2,6-dimethylmorpholinio-carbonsaeureamid-salze, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
ATE10739T1 (de) Substituierte heterocyclische phenoxyamine, verfahren zu ihrer herstellung und ihre verwendung als mittel fuer lokale anaesthesie.
ATE172976T1 (de) 3-aminochroman-spiroderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE46518T1 (de) Sialosylcerebroside und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties